Questioning Conclusions and Statements on the German HTA System: A Critical Perspective.
Saved in:
| Title: | Questioning Conclusions and Statements on the German HTA System: A Critical Perspective. |
|---|---|
| Authors: | Tomeczkowski J; Institute for Evidence-Based Positioning in the Health Care Sector at the University of Bonn, Bonn, Germany., Heidbrede T; UCB BioSciences, Monheim, Germany., Leverkus F; Pfizer Pharma, Berlin, Germany., Schmitter S; Pfizer Pharma, Berlin, Germany., Dintsios CM; Institute for Health Services Research and Health Economics, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany., Osowski U; Merck Healthcare Germany, Darmstadt, Germany., Herrmann KH; Pharming, Ottobrunn, Germany., Bluhmki T; Bristol-Myers Squibb, Munich, Germany., Marx A; Novartis AG, Nuremberg, Germany., Eichinger B; Novartis AG, Nuremberg, Germany., Basic E; Berlin School of Economics and Law, Berlin, Germany., Bussilliat P; vfa Berlin, Berlin, Germany., Dietrich ES; Institute for Evidence-Based Positioning in the Health Care Sector at the University of Bonn, Bonn, Germany. |
| Source: | Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2025 Jan; Vol. 117 (1), pp. 22-23. Date of Electronic Publication: 2024 May 09. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38721790 AccessLevel: 2 PubType: Editorial & Opinion PubTypeId: editorialOpinion PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Questioning Conclusions and Statements on the German HTA System: A Critical Perspective. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Tomeczkowski+J%22">Tomeczkowski J</searchLink>; Institute for Evidence-Based Positioning in the Health Care Sector at the University of Bonn, Bonn, Germany.<br /><searchLink fieldCode="AU" term="%22Heidbrede+T%22">Heidbrede T</searchLink>; UCB BioSciences, Monheim, Germany.<br /><searchLink fieldCode="AU" term="%22Leverkus+F%22">Leverkus F</searchLink>; Pfizer Pharma, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Schmitter+S%22">Schmitter S</searchLink>; Pfizer Pharma, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Dintsios+CM%22">Dintsios CM</searchLink>; Institute for Health Services Research and Health Economics, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.<br /><searchLink fieldCode="AU" term="%22Osowski+U%22">Osowski U</searchLink>; Merck Healthcare Germany, Darmstadt, Germany.<br /><searchLink fieldCode="AU" term="%22Herrmann+KH%22">Herrmann KH</searchLink>; Pharming, Ottobrunn, Germany.<br /><searchLink fieldCode="AU" term="%22Bluhmki+T%22">Bluhmki T</searchLink>; Bristol-Myers Squibb, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Marx+A%22">Marx A</searchLink>; Novartis AG, Nuremberg, Germany.<br /><searchLink fieldCode="AU" term="%22Eichinger+B%22">Eichinger B</searchLink>; Novartis AG, Nuremberg, Germany.<br /><searchLink fieldCode="AU" term="%22Basic+E%22">Basic E</searchLink>; Berlin School of Economics and Law, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Bussilliat+P%22">Bussilliat P</searchLink>; vfa Berlin, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Dietrich+ES%22">Dietrich ES</searchLink>; Institute for Evidence-Based Positioning in the Health Care Sector at the University of Bonn, Bonn, Germany. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220372741%22">Clinical pharmacology and therapeutics</searchLink> [Clin Pharmacol Ther] 2025 Jan; Vol. 117 (1), pp. 22-23. <i>Date of Electronic Publication: </i>2024 May 09. – Name: TypePub Label: Publication Type Group: TypPub Data: Letter – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0372741 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1532-6535 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200099236%22">00099236 </searchLink><i>NLM ISO Abbreviation: </i>Clin Pharmacol Ther <i>Subsets: </i>MEDLINE; In Process |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38721790 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/cpt.3296 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 22 Titles: – TitleFull: Questioning Conclusions and Statements on the German HTA System: A Critical Perspective. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Tomeczkowski J – PersonEntity: Name: NameFull: Heidbrede T – PersonEntity: Name: NameFull: Leverkus F – PersonEntity: Name: NameFull: Schmitter S – PersonEntity: Name: NameFull: Dintsios CM – PersonEntity: Name: NameFull: Osowski U – PersonEntity: Name: NameFull: Herrmann KH – PersonEntity: Name: NameFull: Bluhmki T – PersonEntity: Name: NameFull: Marx A – PersonEntity: Name: NameFull: Eichinger B – PersonEntity: Name: NameFull: Basic E – PersonEntity: Name: NameFull: Bussilliat P – PersonEntity: Name: NameFull: Dietrich ES IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2025 Jan Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1532-6535 Numbering: – Type: volume Value: 117 – Type: issue Value: 1 Titles: – TitleFull: Clinical pharmacology and therapeutics Type: main |
| ResultId | 1 |